Northstar Wealth Partners’s AbbVie ABBV Stock Holding History

Northstar Wealth Partners’s Portfolio ABBV Stock Details ABBV Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2020 Q3	$2.57M	Sell	29,306 -2,666	-8%	-$251K	1.2%	28
2020 Q2	$3.14M	Buy	31,972 +1,045	+3%	+$92K	1.31%	19
2020 Q1	$2.36M	Buy	30,927 +2,190	+8%	+$187K	1.2%	23
2019 Q4	$2.54M	Sell	28,737 -234	-0.8%	-$19.4K	1.04%	26
2019 Q3	$2.19M	Sell	28,971 -46	-0.2%	-$3.15K	0.96%	30
2019 Q2	$2.11M	Buy	29,017 +743	+3%	+$58.4K	0.94%	33
2019 Q1	$2.28M	Sell	28,274 -186	-0.7%	-$15.2K	1.04%	28
2018 Q4	$2.62M	Buy	28,460 +157	+0.6%	+$13.8K	1.38%	20
2018 Q3	$2.68M	Buy	28,303 +2,830	+11%	+$268K	1.28%	22
2018 Q2	$2.36M	Sell	25,473 -816	-3%	-$79.7K	1.18%	23
2018 Q1	$2.49M	Buy	26,289 +21,480	+447%	+$2.36M	1.27%	22
2017 Q4	$478K	Buy	4,809 +1,338	+39%	+$126K	0.42%	72
2017 Q3	$315K	Buy	+3,471	New	+$264K	0.31%	88

Other funds holding ABBV

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Capital Research Global Investors Los Angeles, California $645B AUM 30.41% 1-Year Est. Return

T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

Northern Trust Chicago, Illinois $757B AUM 28.64% 1-Year Est. Return

Berkshire Hathaway Omaha, Nebraska $263B AUM 16.68% 1-Year Est. Return

Northstar Wealth Partners's ABBV Position: Q3 2020 in Review

Northstar Wealth Partners reduced its AbbVie (ABBV) stake by 8.3% in Q3 2020, selling an estimated $251K and leaving 29,306 shares worth $2.57M. The position accounts for 1.2% of the portfolio, ranked #28.

Northstar Wealth Partners first reported a position in ABBV in Q3 2017 and has held it in 13 quarters since. The position peaked at $3.14M in Q2 2020. 2,367 funds tracked by Wall St. Rank hold ABBV as of Q3 2020.

Northstar Wealth Partners held 29,306 shares of AbbVie worth $2.57M as of Q3 2020.
Northstar Wealth Partners sold 2,666 AbbVie shares in Q3 2020, an estimated $251K.
AbbVie made up 1.2% of Northstar Wealth Partners's portfolio in Q3 2020, its #28 holding.
Northstar Wealth Partners first reported a position in AbbVie in Q3 2017 and has held it in 13 quarters since.
Northstar Wealth Partners's AbbVie position peaked at $3.14M in Q2 2020.
2,367 funds tracked by Wall St. Rank held AbbVie as of Q3 2020.

Based on Northstar Wealth Partners's 13F filing for Q3 2020, filed 13 Nov 2020.